Clinical Trial Update: Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating antimony in combination with pentoxifylline for cutaneous leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: Paulo Roberto Lima Machado | Conditions: Cutaneous Leishmaniasis | Phase 2, Phase 3 | Status: COMPLETED